US Stock MarketDetailed Quotes

ZNTL Zentalis Pharmaceuticals

Watchlist
  • 3.620
  • +0.140+4.02%
Close Jul 5 16:00 ET
  • 3.570
  • -0.050-1.38%
Post 16:18 ET
257.07MMarket Cap-1110P/E (TTM)

Zentalis Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
40.56M
0
0
0
0
0
0
0
0
0
Operating revenue
--40.56M
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
0.57%65.33M
11.73%253.94M
31.24%67.92M
15.73%62.72M
-8.06%58.35M
12.22%64.95M
4.96%227.29M
7.39%51.75M
-13.80%54.19M
15.11%63.46M
Selling and administrative expenses
-3.84%15.74M
17.96%64.35M
46.93%16.37M
32.81%15.95M
-20.23%15.66M
39.11%16.37M
33.25%54.55M
14.19%11.14M
35.39%12.01M
89.50%19.64M
-General and administrative expense
-3.84%15.74M
17.96%64.35M
46.93%16.37M
32.81%15.95M
-20.23%15.66M
39.11%16.37M
33.25%54.55M
14.19%11.14M
35.39%12.01M
89.50%19.64M
Research and development costs
2.06%49.59M
9.76%189.59M
26.94%51.56M
10.87%46.77M
-2.60%42.68M
5.36%48.58M
-1.63%172.73M
5.66%40.62M
-21.88%42.18M
-2.11%43.83M
Operating profit
61.87%-24.77M
-11.73%-253.94M
-31.24%-67.92M
-15.73%-62.72M
8.06%-58.35M
-12.22%-64.95M
-4.96%-227.29M
-7.39%-51.75M
13.80%-54.19M
-15.11%-63.46M
Net non-operating interest income expense
Other net income (expense)
750.52%34.95M
-483.35%-22.95M
111.88%6.85M
278.43%7.21M
-9,797.41%-41.12M
864.55%4.11M
-88.48%5.99M
3,572.73%3.23M
-96.31%1.91M
268.70%424K
Gain on sale of security
750.52%34.95M
277.77%22.62M
111.88%6.85M
278.43%7.21M
949.76%4.45M
864.55%4.11M
1,393.02%5.99M
3,572.73%3.23M
1,824.24%1.91M
268.70%424K
Special income (charges)
----
---45.57M
--0
--0
---45.57M
----
--0
--0
--0
--0
-Less:Other special charges
----
--45.57M
--0
----
--45.57M
----
----
----
----
----
-Gain on sale of business
----
--0
----
----
----
----
--0
----
----
----
Income before tax
116.74%10.18M
-25.12%-276.89M
-25.87%-61.07M
-6.16%-55.51M
-57.79%-99.47M
-5.90%-60.84M
-34.48%-221.3M
-0.87%-48.52M
-367.32%-52.29M
-14.58%-63.04M
Income tax
32.41%143K
-28.14%-601K
62.50%-135K
119.50%31K
-3,658.82%-605K
227.27%108K
-57.91%-469K
-326.42%-360K
77.19%-159K
-62.22%17K
Earnings from equity interest net of tax
--0
1.65%-16.01M
--0
--0
-156.73%-13.7M
-31.92%-2.31M
-789.24%-16.28M
-272.58%-6.82M
---2.37M
---5.34M
Net income
115.87%10.04M
-23.28%-292.31M
-10.83%-60.94M
-1.91%-55.54M
-64.59%-112.56M
-6.79%-63.26M
-42.76%-237.11M
-9.76%-54.98M
-419.44%-54.5M
-24.21%-68.39M
Net income continuous Operations
115.87%10.04M
-23.28%-292.31M
-10.83%-60.94M
-1.91%-55.54M
-64.59%-112.56M
-6.79%-63.26M
-42.76%-237.11M
-9.76%-54.98M
-419.44%-54.5M
-24.21%-68.39M
Minority interest income
34.88%-28K
62.87%-114K
-69.23%-22K
87.88%-12K
-5.71%-37K
73.13%-43K
95.83%-307K
63.89%-13K
98.43%-99K
92.83%-35K
Net income attributable to the parent company
115.93%10.07M
-23.39%-292.19M
-10.82%-60.92M
-2.07%-55.53M
-64.62%-112.53M
-7.01%-63.22M
-49.19%-236.81M
-9.81%-54.97M
-1,198.04%-54.4M
-25.26%-68.36M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
115.93%10.07M
-23.39%-292.19M
-10.82%-60.92M
-2.07%-55.53M
-64.62%-112.53M
-7.01%-63.22M
-49.19%-236.81M
-9.81%-54.97M
-1,198.04%-54.4M
-25.26%-68.36M
Basic earnings per share
113.08%0.14
0.22%-4.47
9.78%-0.83
17.71%-0.79
-38.06%-1.85
18.32%-1.07
-20.43%-4.48
17.12%-0.92
-966.67%-0.96
0.00%-1.34
Diluted earnings per share
113.08%0.14
0.22%-4.47
9.78%-0.83
17.71%-0.79
-38.06%-1.85
18.32%-1.07
-20.43%-4.48
17.12%-0.92
-966.67%-0.96
0.00%-1.34
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 40.56M000000000
Operating revenue --40.56M--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 0.57%65.33M11.73%253.94M31.24%67.92M15.73%62.72M-8.06%58.35M12.22%64.95M4.96%227.29M7.39%51.75M-13.80%54.19M15.11%63.46M
Selling and administrative expenses -3.84%15.74M17.96%64.35M46.93%16.37M32.81%15.95M-20.23%15.66M39.11%16.37M33.25%54.55M14.19%11.14M35.39%12.01M89.50%19.64M
-General and administrative expense -3.84%15.74M17.96%64.35M46.93%16.37M32.81%15.95M-20.23%15.66M39.11%16.37M33.25%54.55M14.19%11.14M35.39%12.01M89.50%19.64M
Research and development costs 2.06%49.59M9.76%189.59M26.94%51.56M10.87%46.77M-2.60%42.68M5.36%48.58M-1.63%172.73M5.66%40.62M-21.88%42.18M-2.11%43.83M
Operating profit 61.87%-24.77M-11.73%-253.94M-31.24%-67.92M-15.73%-62.72M8.06%-58.35M-12.22%-64.95M-4.96%-227.29M-7.39%-51.75M13.80%-54.19M-15.11%-63.46M
Net non-operating interest income expense
Other net income (expense) 750.52%34.95M-483.35%-22.95M111.88%6.85M278.43%7.21M-9,797.41%-41.12M864.55%4.11M-88.48%5.99M3,572.73%3.23M-96.31%1.91M268.70%424K
Gain on sale of security 750.52%34.95M277.77%22.62M111.88%6.85M278.43%7.21M949.76%4.45M864.55%4.11M1,393.02%5.99M3,572.73%3.23M1,824.24%1.91M268.70%424K
Special income (charges) -------45.57M--0--0---45.57M------0--0--0--0
-Less:Other special charges ------45.57M--0------45.57M--------------------
-Gain on sale of business ------0------------------0------------
Income before tax 116.74%10.18M-25.12%-276.89M-25.87%-61.07M-6.16%-55.51M-57.79%-99.47M-5.90%-60.84M-34.48%-221.3M-0.87%-48.52M-367.32%-52.29M-14.58%-63.04M
Income tax 32.41%143K-28.14%-601K62.50%-135K119.50%31K-3,658.82%-605K227.27%108K-57.91%-469K-326.42%-360K77.19%-159K-62.22%17K
Earnings from equity interest net of tax --01.65%-16.01M--0--0-156.73%-13.7M-31.92%-2.31M-789.24%-16.28M-272.58%-6.82M---2.37M---5.34M
Net income 115.87%10.04M-23.28%-292.31M-10.83%-60.94M-1.91%-55.54M-64.59%-112.56M-6.79%-63.26M-42.76%-237.11M-9.76%-54.98M-419.44%-54.5M-24.21%-68.39M
Net income continuous Operations 115.87%10.04M-23.28%-292.31M-10.83%-60.94M-1.91%-55.54M-64.59%-112.56M-6.79%-63.26M-42.76%-237.11M-9.76%-54.98M-419.44%-54.5M-24.21%-68.39M
Minority interest income 34.88%-28K62.87%-114K-69.23%-22K87.88%-12K-5.71%-37K73.13%-43K95.83%-307K63.89%-13K98.43%-99K92.83%-35K
Net income attributable to the parent company 115.93%10.07M-23.39%-292.19M-10.82%-60.92M-2.07%-55.53M-64.62%-112.53M-7.01%-63.22M-49.19%-236.81M-9.81%-54.97M-1,198.04%-54.4M-25.26%-68.36M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 115.93%10.07M-23.39%-292.19M-10.82%-60.92M-2.07%-55.53M-64.62%-112.53M-7.01%-63.22M-49.19%-236.81M-9.81%-54.97M-1,198.04%-54.4M-25.26%-68.36M
Basic earnings per share 113.08%0.140.22%-4.479.78%-0.8317.71%-0.79-38.06%-1.8518.32%-1.07-20.43%-4.4817.12%-0.92-966.67%-0.960.00%-1.34
Diluted earnings per share 113.08%0.140.22%-4.479.78%-0.8317.71%-0.79-38.06%-1.8518.32%-1.07-20.43%-4.4817.12%-0.92-966.67%-0.960.00%-1.34
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg